SCHEMBL6780256

SCHEMBL6780256

CCNC1CCCC(c2nc3c(C(N)=O)cccc3[nH]2)C1

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 20/20 0.60
PARP2 Q9UGN5 3/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6787531 0.92 PARP1 (0.59) PARP1PARP2
SCHEMBL6782073 0.87 PARP1 (0.69) PARP1PARP2
SCHEMBL6780260 0.84 PARP1 (0.42) PARP1PARP2
SCHEMBL6782558 0.83 PARP1 (0.63) PARP1PARP2
SCHEMBL5072039 0.83 PARP1 (0.67) PARP1PARP2
SCHEMBL6777880 0.82 PARP1 (0.61) PARP1PARP2
SCHEMBL6781857 0.82 PARP1 (0.68) PARP1PARP2
SCHEMBL6777821 0.82 PARP1 (0.68) PARP1PARP2
SCHEMBL5074006 0.81 PARP1 (0.76) PARP1PARP2
SCHEMBL6782904 0.81 PARP1 (0.64) PARP1PARP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6737421-B1 4-CARBOXYAMIDO SUBSTITUTED; NEURODEGENERATIVE DISEASES; NEURONAL DAMAGE ABBOTT GMBH & CO. KG (DE) 2004-05-18 US disclosed